Martin Lipp

Follow

Person

Glienicke, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Antibody that binds CD269 (BCMA) suitable for use in the treatment...
- Patent number 11,667,722
- Issue date Jun 6, 2023
- MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT
- Martin Lipp
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody that binds CD269 (BCMA) suitable for use in the treatment...
- Patent number 10,745,486
- Issue date Aug 18, 2020
- Max-Delbruck-Centrum für Molekulare Medizin
- Martin Lipp
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody that binds CD269 (BCMA) suitable for use in the treatment...
- Patent number 10,189,906
- Issue date Jan 29, 2019
- MAX-DELRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN
- Martin Lipp
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODY THAT BINDS CD269 (BCMA) SUITABLE FOR USE IN THE TREATMENT...
- Publication number 20200369778
- Publication date Nov 26, 2020
- MAX-DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT
- Martin LIPP
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY THAT BINDS CD269 (BCMA) SUITABLE FOR USE IN THE TREATMENT...
- Publication number 20190106499
- Publication date Apr 11, 2019
- Max-Delbruck-Centrum fur molekulare Medizin
- Martin Lipp
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY THAT BINDS CD269 (BCMA) SUITABLE FOR USE IN THE TREATMENT...
- Publication number 20150284467
- Publication date Oct 8, 2015
- Max-Delbruck-Centrum fur molekulare Medizin
- Martin Lipp
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE